MALVERN, PA — Ocugen Inc. (Nasdaq: OCGN) will host a conference call and live webcast at 8:30 a.m. Eastern on Wednesday, March 4, 2026, to discuss its fourth-quarter and full-year 2025 financial results and provide a business update, the company announced.
Ocugen said it will issue its earnings results before the market opens that day.
Investors may participate by dialing (800) 715-9871 in the United States or (646) 307-1963 internationally, using conference ID 3029428.
A live webcast will be available on the events section of the company’s investor website at https://ocugen.com/events/. A replay and archived webcast will be accessible at https://ir.ocugen.com/.
Ocugen is a biotechnology company developing gene therapies for blindness-related diseases. Its pipeline includes programs targeting inherited retinal diseases and other vision conditions, including retinitis pigmentosa, Stargardt disease and geographic atrophy associated with late-stage dry age-related macular degeneration.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.